In parallel experiments, they showed that inflammatory cytokine release was suppressed by recombinant ST6GAL1 infusion in these mice and suggested a potential role for ST6GAL1 in diseases like COPD. This evidence concerns the gene ST6GAL1 and chronic obstructive pulmonary disease.